Skip to content
Summer 2026 · 26% off every plan with SUMMER26 See pricing
Optionomics
CDLX · 10-Q filed May 7, 2026

CDLX earnings analysis

What we found in CDLX's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.

Our reading of the filing · Free to read, no account needed

Cardlytics reported a Q1 2026 revenue of $34.3 million, down 39% year-over-year, falling short of estimates of $37.1 million. Despite missing on revenue, the company showed an EPS of -$0.11, an improvement from the expected -$0.24, reflecting operational losses narrowing year-over-year. Management has provided guidance for Q2 2026 revenues expecting between $35 million and $40 million, indicating a continued decline from the prior year.

What stood out

The parts that mattered.

Pulled out of the filing itself, with the figures the company reported.

Revenue Decline
Q1 2026 revenue was $34.3M, down 39% YoY from $56.4M.
Narrowed EPS Loss
Reported EPS improved to -$0.11 from -$0.26 YoY, better than the -$0.24 estimate.
Successful Bridg Divestiture
The sale of the Bridg platform resulted in a gain of $14.5M on divestiture.
Reduced Partner Share Costs
Partner share costs dropped to $14.6M, a 50% decline from $29.1M YoY.
Positive Cash Flow from Operations
Despite losses, Q1 2026 saw net cash used in operating activities improve to -$5.6M from -$6.7M YoY.
Increased Working Capital
Working capital rose to $69.2M from $58.9M at year-end 2025.
What to watch

And the other side of it.

The offsets in the same document — the things a summary that only listed the good news would have left out.

Revenue Misses Estimates
Reported revenue of $34.3M fell short of consensus estimates of $37.1M.
MQUs Down 8%
Monthly Qualified Users decreased to 197,011 from 214,891 YoY.
Negative Free Cash Flow
Free cash flow was -$7.9M, worsening from -$10.8M YoY.
The numbers

What they reported.

What the company itself reported, taken out of the document.

Earnings per share
$-0.11
Gross margin
50.0%
Guidance

What they said about what is next.

Management anticipates Q2 2026 revenue between $35M-$40M, reflecting a decline of 40%-31% YoY.

How we read the filing overall

The filing reads worse than the one before it.

One reading of one document. It is not advice, and it is not a forecast.
Earlier filings

What came before.

10-K · March 4, 2026
Cardlytics positions itself as a commerce media platform built on a financial media network (Cardlytics) and a POS/identity platform (Bridg). The company highlights network effects and data scale — analyzing…
10-Q · November 5, 2025
Cardlytics reported Q3 2025 revenue of $52.0M and GAAP net loss of $72.7M (EPS $(1.36)). Revenue declined year-over-year but gross margin improved; operating loss narrowed materially versus prior-year quarter. The…
10-Q · August 6, 2025
Cardlytics reported Q2 2025 revenue of $63,249,000, a small sequential increase versus Q1 2025 ($61,898,000) but a year-over-year decline versus Q2 2024 ($69,636,000). Operating loss improved to $12,789,000 in Q2 2025…
10-Q · August 7, 2024
Cardlytics, Inc. reported a decrease in revenue for Q2 2024, with $69.6 million, down 9.5% from $76.7 million in Q2 2023. The company incurred a net loss of $4.3 million, resulting in an EPS of -$0.09, which reflects a…

This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.

Read the next one first.

We read every filing CDLX makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.

Cancel anytime · Month to month · Switch tiers whenever